Literature DB >> 12196134

Glutamine repeats: structural hypotheses and neurodegeneration.

L Masino1, A Pastore.   

Abstract

A growing number of neurodegenerative diseases are caused by expansion of CAG trinucleotide repeats coding for polyglutamine. The presence of intranuclear inclusions in the affected neuronal cells has suggested a mechanism for pathogenesis based on protein misfolding and aggregation. Detailed understanding of these phenomena is therefore crucial in order to rationalize different phases of the diseases. In the past decade, a few studies have focused on the structural properties of polyglutamine and on the molecular bases of the aggregation process. Most of these studies have been performed on polyglutamine peptides and protein models. Only one report is currently available on the characterization of a full-length polyglutamine protein. The structural hypotheses resulting from these studies are reviewed here.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12196134     DOI: 10.1042/bst0300548

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  4 in total

Review 1.  From Alzheimer to Huntington: why is a structural understanding so difficult?

Authors:  Piero Andrea Temussi; Laura Masino; Annalisa Pastore
Journal:  EMBO J       Date:  2003-02-03       Impact factor: 11.598

2.  Molecular origin of polyglutamine aggregation in neurodegenerative diseases.

Authors:  Sagar D Khare; Feng Ding; Kenneth N Gwanmesia; Nikolay V Dokholyan
Journal:  PLoS Comput Biol       Date:  2005-08-26       Impact factor: 4.475

3.  TOX defines a conserved subfamily of HMG-box proteins.

Authors:  Emmett O'Flaherty; Jonathan Kaye
Journal:  BMC Genomics       Date:  2003-04-02       Impact factor: 3.969

4.  The relationship between aggregation and toxicity of polyglutamine-containing ataxin-3 in the intracellular environment of Escherichia coli.

Authors:  Gaetano Invernizzi; Francesco A Aprile; Antonino Natalello; Andrea Ghisleni; Amanda Penco; Annalisa Relini; Silvia M Doglia; Paolo Tortora; Maria E Regonesi
Journal:  PLoS One       Date:  2012-12-14       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.